Valeant Pharmaceuticals Buying PreCision Dermatology for $475 Million

NEW YORK (AP) -- Valeant Pharmaceuticals is looking to expand its skin care business by buying PreCision Dermatology for $475 million.

Cumberland, R.I.-based PreCision Dermatology makes treatments for skin ailments such as acne and atopic dermatitis, an itchy, chronic skin inflammation.

Valeant, which is based in Canada, said Monday that PreCision expects to have about $130 million in revenue in 2014. It said the purchase should close by the end of June and will add to its adjusted earnings immediately.

Valeant hasn't reported its full 2013 results, but has forecast $5.7 billion to $5.9 billion in revenue for the year.

The company could pay another $25 million if a certain sales target is reached.

The stock has doubled over the past 12 months.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2820571, ~/Articles/ArticleHandler.aspx, 9/16/2014 7:57:59 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement